# US 2010/0166765 A1 · Benzoquinazoline derivatives

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2010/0166765 A1
- Document ID: US20100166765A1
- Status: Published application
- Kind: A1
- Application number: 12/063,526
- Filed: 2006-08-14
- Published: 2010-07-01
- Earliest claimed: 2005-08-15
- Inventors: Sandra Ammon; Rene Beerli; Leo Widler
- Web page: https://patentgrep.com/patent/US20100166765A1

## CPC

- C07D 409/06: linked by a carbon chain containing only aliphatic carbon atoms
- A61P 5/18: of the parathyroid hormones
- A61P 19/00: Drugs for skeletal disorders
- A61P 19/08: for bone diseases, e.g. rachitism, Paget's disease
- A61P 19/10: for osteoporosis
- C07D 217/12: with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring
- C07D 217/26: Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D 239/70: condensed with carbocyclic rings or ring systems
- C07D 401/06: linked by a carbon chain containing only aliphatic carbon atoms
- C07D 401/12: linked by a chain containing hetero atoms as chain links
- C07D 403/06: linked by a carbon chain containing only aliphatic carbon atoms
- C07D 403/12: linked by a chain containing hetero atoms as chain links
- C07D 405/06: linked by a carbon chain containing only aliphatic carbon atoms
- C07D 405/12: linked by a chain containing hetero atoms as chain links
- C07D 409/12: linked by a chain containing hetero atoms as chain links
- C07D 417/06: linked by a carbon chain containing only aliphatic carbon atoms
- C07D 417/12: linked by a chain containing hetero atoms as chain links
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

A compound of formula (I) or a pharmaceutically acceptable salt or prodrug ester thereof, wherein the groups R2, R3, R4, Q, X and Y are as defined in the specification, is useful in the treatment of bone conditions related to increased calcium depletion or resorption.

## Claims

### Claim 1

A compound of formula (I) or a pharmaceutically acceptable salt or prodrug ester thereof:
wherein:
Q is CH or N;
R2 is C1-C4 alkyl;
Y is selected from the group consisting of: R5-O—, C1-C4 alkyl, C1-C4 alkenyl, C1-C4 alkynyl, R5-NH—;
where R5 is C1-C4 alkyl, C1-C4 alkenyl, C1-C4 alkynyl;
X is selected from the group consisting of aryl, heteroaryl, C1-C10 alkyl, C1-C10 alkyloxy, cycloalkyl, heterocycloalkyl, aryl C1-C4 alkyl, heteroaryl C1-C4 alkyl, cycloalkyl C1-C4 alkyl, heterocycloalkyl C1-C4 alkyl, arylamino, heteroarylamino, aryl C1-C4 alkylamino, heteroaryl C1-C4 alkylamino, C1-C6 alkylamino, C1-C6dialkylamino, aryloxy, heteroaryloxy, aryl C1-C4 alkyloxy, heteroaryl C1-C4 alkyloxy, cycloalkyl C1-C4 alkylamino, heterocycloalkyl C1-C4 alkylamino, cycloalkyl C1-C4 alkyloxy or heterocycloalkyl C1-C4 alkyloxy each of which is optionally substituted once or more;
the optional substituent or substituents on X being independently selected from the group consisting of halo, cyano, trifluoromethyl, nitro, hydroxy, optionally substituted (C1-C4 alkyl, C1-C4 alkyloxy, amino, sulfanyl, sulfonyl, amino, oxycarbonyl, hydroxyl, sulfinyl, aminosulfonyl, sulfonylamino, carbonyl, carbonyloxy, carbonyl amino, carboxyl, acyl, acylamino, or carbamoyl); the optional substituent or substituents being selected from C1-C6 alkyl, C1-C6 alkyloxy, carboxyl, hydroxyl, hydroxy C1-C4 alkyl; each of which in turn may be optionally substituted by C1-C6 alkyloxy, C1-C6 alkyl, C1-C3 fluorinated alkyl, C1-C6 alkyloxy, carboxyl, hydroxyl, hydroxy C1-C4 alkyl, halo, cyano, nitro.
R3 and R4 each represent one or more substituents independently selected from: H, halo, C1-C4 alkyl, C1-C4 alkyloxy, CF3;
the optional substituent or substituents on R3 or R4 being independently selected from the group consisting of C1-C4 alkyl, halo, C1-C4 alkyloxy, cyano, sulfanyl, sulfonyl, amino, oxycarbonyl, hydroxyl which may in turn be optionally substituted once or more by C1-C4 alkyl, halo, C1-C4 alkyloxy, cyano, sulfanyl, sulfonyl, amino, oxycarbonyl or hydroxyl.

### Claim 2

A compound of formula (I′) or a pharmaceutically acceptable salt or prodrug ester thereof:
wherein:
Q is CH or N;
R2 is C1-C4 alkyl;
Y is selected from the group consisting of: R5-O—, C1-C4 alkyl, C1-C4 alkenyl, C1-C4 alkynyl, R5-NH—;
where R5 is C1-C4 alkyl, C1-C4 alkenyl, C1-C4 alkynyl;
X is selected from the group consisting of aryl, heteroaryl, C1-C6 alkyl, cycloalkyl, heterocycloalkyl, aryl C1-C4 alkyl, heteroaryl C1-C4 alkyl, arylamino, aryl C1-C4 alkylamino, heteroaryl C1-C4 alkylamino, C1-C6 alkylamino, C1-C6dialkylamino amino, aryloxy, heteroaryloxy, aryl C1-C4 alkyloxy, or heteroaryl C1-C4 alkyloxy, each of which is optionally substituted once or more;
the optional substituent or substituents on X being independently selected from the group consisting of C1-C4 alkyl, halo, C1-C4 alkyloxy, cyano, trifluoromethyl, hydroxy, amino, nitro, alkyl, lower alkyl substituted (sulfanyl, sulfonyl, amino, oxycarbonyl, hydroxyl, sulfinyl, carbonyl, carboxyl, carbamoyl or aminoacyl);
R3 and R4 each represent one or more substituents independently selected from: H, halo, optionally substituted C1-C4 alkyl, optionally substituted C1-C4 alkyloxy;
the optional substituent or substituents on R3 or R4 being independently selected from the group consisting of C1-C4 alkyl, halo, C1-C4 alkyloxy, cyano, sulfanyl, sulfonyl, amino, oxycarbonyl, hydroxyl.

### Claim 3 (depends on 1)

A compound of according to claim 1 having the formula (II) or a pharmaceutically acceptable salt or prodrug ester thereof:
wherein:
X′ is selected from the group consisting of aryl, heteroaryl, cycloalkyl, heterocycloalkyl, —C1-C4 alkylaryl, —C1-C4 alkylheteroaryl, arylamino, heteroarylamino, aryl C1-C4 alkylamino, heteroaryl C1-C4 alkylamino, aryloxy, heteroaryloxy, aryl C1-C4 alkyloxy, heteroaryl C1-C4 alkyloxy, aryl C1-C4 alkyl, heteroaryl C1-C4 alkyl, C1-C6 alkyl, —C1-C4 alkylamino or amino, each of which is optionally substituted once or more;
the optional substituent or substituents on X′ being independently selected from the group consisting of halo, cyano, trifluoromethyl, nitro, hydroxy, optionally substituted (C1-C4 alkyl, C1-C4 alkyloxy, amino, sulfanyl, sulfonyl, amino, oxycarbonyl, hydroxyl, sulfinyl, carbonyl, carboxyl, acyl, acylamino, carbamoyl or aminoacyl); the optional substituent or substituents being selected from C1-C6 alkyl, C1-C6 alkyloxy, carboxyl, hydroxyl, hydroxy C1-C4 alkyl; each of which in turn may be optionally substituted by C1-C6 alkyloxy, C1-C6 alkyl, C1-C6 alkyloxy, carboxyl, hydroxyl, hydroxy C1-C4 alkyl, halo, cyano, nitro.
R2′ is C1-C4 alkyl.

### Claim 4 (depends on 1)

A compound of according to claim 1 having the formula (II) or a pharmaceutically acceptable salt or prodrug ester thereof:
wherein:
X′ is selected from the group consisting of aryl, heteroaryl, cycloalkyl, heterocycloalkyl, C1-C4 alkylaryl, C1-C4 alkylheteroaryl, C1-C4 alkyl, C1-C4 alkylamino or amino, each of which is optionally substituted once or more;
the optional substituent or substituents on X′ being independently selected from the group consisting of C1-C4 alkyl, halo, C1-C4 alkyloxy, cyano, trifluoromethyl, hydroxy, amino, nitro, alkyl, lower alkyl substituted (sulfanyl, sulfonyl, amino, oxycarbonyl, hydroxyl, sulfinyl, carbonyl, carboxyl, carbamoyl or aminoacyl);
R2′ is C1-C4 alkyl.

### Claim 5 (depends on 3)

A compound according to claim 3 wherein R2′ is isopropyl, t-butyl or cyclopropyl.

### Claim 6 (depends on 2)

A compound according to claim 2 wherein X′ is optionally substituted (aryl, heteroaryl, heterocycloalkyl, arylamino, heteroarylamino, aryl C1-C4 alkylamino, heteroaryl C1-C4 alkylamino, aryloxy, heteroaryloxy, C1-C6 alkyloxy, aryl C1-C4 alkyloxy, heteroaryl C1-C4 alkyloxy).

### Claim 7 (depends on 1)

A compound according to claim 1 selected from the following:
(4-tert-Butyl-phenyl)-[4-(4-isopropyl-phenyl)-6-propargyloxy-quinazolin-2-yl]-methanone;
[4-(4-Isopropyl-phenyl)-6-propargyloxy-quinazolin-2-yl]-phenyl-methanone;
(2-Methoxy-phenyl)-[4-(4-Isopropyl-phenyl)-6-propargyloxy-quinazolin-2-yl]-methanone;
(3-Methoxy-phenyl)-[4-(4-Isopropyl-phenyl)-6-propargyloxy-quinazolin-2-yl]-methanone;
(4-Methoxy-phenyl)-[4-(4-Isopropyl-phenyl)-6-propargyloxy-quinazolin-2-yl]-methanone;
(4-Fluoro-phenyl)-[4-(4-isopropyl-phenyl)-6-propargyloxy-quinazolin-2-yl]-methanone;
(3-Fluoro-phenyl)-[4-(4-isopropyl-phenyl)-6-propargyloxy-quinazolin-2-yl]-methanone;
(3-Chloro-phenyl)-[4-(4-isopropyl-phenyl)-6-propargyloxy-quinazolin-2-yl]-methanone;
(4-Chloro-phenyl)-[4-(4-isopropyl-phenyl)-6-propargyloxy-quinazolin-2-yl]-methanone;
(4-Fluoro-phenyl)-[4-(4-tert.butyl-phenyl)-6-propargyloxy-quinazolin-2-yl]-methanone;
(3-Fluoro-phenyl)-[4-(4-tert.butyl-phenyl)-6-propargyloxy-quinazolin-2-yl]-methanone;
(3-Bromo-phenyl)-[4-(4-isopropyl-phenyl)-6-propargyloxy-quinazolin-2-yl]-methanone;
(4-Bromo-phenyl)-[4-(4-isopropyl-phenyl)-6-propargyloxy-quinazolin-2-yl]-methanone;
(4-Methyl-phenyl)-[4-(4-isopropyl-phenyl)-6-propargyloxy-quinazolin-2-yl]-methanone;
(4-Isopropyl-phenyl)-[4-(4-isopropyl-phenyl)-6-propargyloxy-quinazolin-2-yl]-methanone;
(4-Ethyl-phenyl)-[4-(4-isopropyl-phenyl)-6-propargyloxy-quinazolin-2-yl]-methanone;
(4-Propyl-phenyl)-[4-(4-isopropyl-phenyl)-6-propargyloxy-quinazolin-2-yl]-methanone;
(4-Cyano-phenyl)-[4-(4-isopropyl-phenyl)-6-propargyloxy-quinazolin-2-yl]-methanone;
(4-Methylthio-phenyl)-[4-(4-isopropyl-phenyl)-6-propargyloxy-quinazolin-2-yl]-methanone;
(4-Methansulfonyl-phenyl)-[4-(4-isopropyl-phenyl)-6-propargyloxy-quinazolin-2-yl]-methanone;
(4-Dimethylamino-phenyl)-[4-(4-isopropyl-phenyl)-6-propargyloxy-quinazolin-2-yl]-methanone;
(4-Ethoxy-phenyl)-[4-(4-isopropyl-phenyl)-6-propargyloxy-quinazolin-2-yl]-methanone;
4-[4-(4-Isopropyl-phenyl)-6-propargyloxy-quinazoline-2-carbonyl]-benzoic acid methyl ester;
(4-Dimethylamino-phenyl)-[4-(4-tert.butyl-phenyl)-6-propargyloxy-quinazolin-2-yl]-methanone;
(4-Dimethylamino-phenyl)-[4-(4-cyclopropyl-phenyl)-6-propargyloxy-quinazolin-2-yl]-methanone;
4-[4-(4-Isopropyl-phenyl)-6-propargyloxy-quinazoline-2-carbonyl]-benzoic acid ethyl ester;
(4-Methoxy-phenyl)-[4-(4-tert.butyl-phenyl)-6-propargyloxy-quinazolin-2-yl]-methanone;
(4-Ethoxy-phenyl)-[4-(4-cyclopropyl-phenyl)-6-propargyloxy-quinazolin-2-yl]-methanone;
(3-Ethoxy-4-methoxy-phenyl)-[4-(4-isopropyl-phenyl)-6-propargyloxy-quinazolin-2-yl]-methanone;
(4-tert.Butyloxy-phenyl)-[4-(4-isopropyl-phenyl)-6-propargyloxy-quinazolin-2-yl]-methanone;
(4-Hydroxy)-[4-(4-isopropyl-phenyl)-6-propargyloxy-quinazolin-2-yl]-methanone;
(4-Butyloxy)-[4-(4-isopropyl-phenyl)-6-propargyloxy-quinazolin-2-yl]-methanone;
Furan-2-yl-[4-(4-isopropyl-phenyl)-6-propargyloxy-quinazolin-2-yl]-methanone;
Furan-3-yl-[4-(4-tert.butyl-phenyl)-6-propargyloxy-quinazolin-2-yl]-methanone;
Furan-3-yl-[4-(4-isopropyl-phenyl)-6-propargyloxy-quinazolin-2-yl]-methanone;
Thiophen-2-yl-[4-(4-isopropyl-phenyl)-6-propargyloxy-quinazolin-2-yl]-methanone;
(3-Methyl-thiophen-2-yl-[4-(4-isopropyl-phenyl)-6-propargyloxy-quinazolin-2-yl]-methanone;
Benz[b]thiophen-2-yl-[4-(4-isopropyl-phenyl)-6-propargyloxy-quinazolin-2-yl]-methanone;
Thiophen-3-yl-[4-(4-isopropyl-phenyl)-6-propargyloxy-quinazolin-2-yl]-methanone;
(1-Methyl-1H-pyrrol)-2-yl-[4-(4-isopropyl-phenyl)-6-propargyloxy-quinazolin-2-yl]-methanone;
4-(4-Isopropyl-phenyl)-6-propargyloxy-quinazoline-2-carboxylic acid ethyl ester;
[4-(4-isopropyl-phenyl)-6-propargyloxy-quinazolin-2-yl]-pyridine-3-yl-methanone;
[4-(4-Isopropyl-phenyl)-6-propargyloxy-quinazolin-2-yl]-naphthalen-1-yl-methanone;
[4-(4-Isopropyl-phenyl)-6-propargyloxy-naphathalen-2-yl]-methanone;
Benzothiazol-2-yl-[4-(4-isopropyl-phenyl)-6-propargyloxy-quinazolin-2-yl]-methanone;
[4-(4-Isopropyl-phenyl)-6-propargyloxy-quinazolin-2-yl]-thiazol-5-yl-methanone;
[4-(4-Isopropyl-phenyl)-6-propargyloxy-quinazolin-2-yl]-piperidin-1-yl-methanone;
4-(4-Isopropyl-phenyl)-6-prop-2-ynyloxy-quinazoline-2-carboxylic acid (3-chloro-phenyl)-amide;
4-(4-Isopropyl-phenyl)-6-prop-2-ynyloxy-quinazoline-2-carboxylic acid (3-methoxy-phenyl)-amide;
4-(4-Isopropyl-phenyl)-6-prop-2-ynyloxy-3,4-dihydro-quinazoline-2-carboxylic acid (3-methylsulfanyl-phenyl)-amide;
4-(4-Isopropyl-phenyl)-6-prop-2-ynyloxy-3,4-dihydro-quinazoline-2-carboxylic acid (3-methanesulfonyl-phenyl)-amide;
4-(4-Isopropyl-phenyl)-6-prop-2-ynyloxy-quinazoline-2-carboxylic acid (3-trifluoromethylsulfanyl-phenyl)-amide;
4-(4-Isopropyl-phenyl)-6-prop-2-ynyloxy-3,4-dihydro-quinazoline-2-carboxylic acid (3-sulfamoyl-phenyl)-amide;
4-(4-Isopropyl-phenyl)-6-prop-2-ynyloxy-3,4-dihydro-quinazoline-2-carboxylic acid [3-(2-hydroxy-ethanesulfonyl)-phenyl]-amide;
4-(4-Isopropyl-phenyl)-6-prop-2-ynyloxy-3,4-dihydro-quinazoline-2-carboxylic acid (5-ethanesulfonyl-2-hydroxy-phenyl)-amide;
4-(4-Isopropyl-phenyl)-6-prop-2-ynyloxy-quinazoline-2-carboxylic acid (3-nitro-phenyl)-amide;
4-(4-Isopropyl-phenyl)-6-prop-2-ynyloxy-quinazoline-2-carboxylic acid (3-cyano-phenyl)-amide;
3-{[4-(4-Isopropyl-phenyl)-6-prop-2-ynyloxy-quinazoline-2-carbonyl]-amino}-benzoic acid methyl ester;
3-{[4-(4-Isopropyl-phenyl)-6-prop-2-ynyloxy-quinazoline-2-carbonyl]-amino}-benzoic acid ethyl ester;
3-{[4-(4-Isopropyl-phenyl)-6-prop-2-ynyloxy-quinazoline-2-carbonyl]-amino}-benzoic acid isopropyl ester;
3-{[4-(4-Isopropyl-phenyl)-6-prop-2-ynyloxy-quinazoline-2-carbonyl]-amino}-benzoic acid tert-butyl ester;
4-(4-Isopropyl-phenyl)-6-prop-2-ynyloxy-quinazoline-2-carboxylic acid (3-carbamoyl-phenyl)-amide;
4-(4-Isopropyl-phenyl)-6-prop-2-ynyloxy-quinazoline-2-carboxylic acid (3-acetyl-phenyl)-amide;
3-{[4-(4-Isopropyl-phenyl)-6-prop-2-ynyloxy-quinazoline-2-carbonyl]-amino}-5-methoxy-benzoic acid methyl ester;
4-(4-Isopropyl-phenyl)-6-prop-2-ynyloxy-quinazoline-2-carboxylic acid (3-methylcarbamoyl-phenyl)-amide;
4-(4-Isopropyl-phenyl)-6-prop-2-ynyloxy-quinazoline-2-carboxylic acid (3-tert-butylcarbamoyl-phenyl)-amide;
4-(4-Isopropyl-phenyl)-6-prop-2-ynyloxy-quinazoline-2-carboxylic acid (3-dimethylcarbamoyl-5-trifluoromethyl-phenyl)-amide;
3-{[4-(4-Isopropyl-phenyl)-6-prop-2-ynyloxy-quinazoline-2-carbonyl]-amino}-5-trifluoromethyl-benzoic acid methyl ester;
3-{[4-(4-Isopropyl-phenyl)-6-prop-2-ynyloxy-quinazoline-2-carbonyl]-amino}-5-trifluoromethyl-benzoic acid isopropyl ester;
2-Fluoro-5-{[4-(4-isopropyl-phenyl)-6-prop-2-ynyloxy-quinazoline-2-carbonyl]-amino}-benzoic acid methyl ester;
2-Fluoro-5-{[4-(4-isopropyl-phenyl)-6-prop-2-ynyloxy-quinazoline-2-carbonyl]-amino}-benzoic acid isopropyl ester;
2-Chloro-5-{[4-(4-isopropyl-phenyl)-6-prop-2-ynyloxy-quinazoline-2-carbonyl]-amino}-benzoic acid methyl ester;
2,5-Dichloro-3-{[4-(4-isopropyl-phenyl)-6-prop-2-ynyloxy-quinazoline-2-carbonyl]-amino}-benzoic acid methyl ester;
2,5-Dichloro-3-{[4-(4-isopropyl-phenyl)-6-prop-2-ynyloxy-quinazoline-2-carbonyl]-amino}-benzoic acid isopropyl ester;
4-(4-Isopropyl-phenyl)-6-prop-2-ynyloxy-quinazoline-2-carboxylic acid (3-cyano-5-fluoro-phenyl)-amide;
4-(4-Isopropyl-phenyl)-6-prop-2-ynyloxy-quinazoline-2-carboxylic acid (3,4-dicyano-phenyl)-amide;
4-(4-Isopropyl-phenyl)-6-prop-2-ynyloxy-quinazoline-2-carboxylic acid (4-cyano-3-trifluoromethyl-phenyl)-amide;
4-(4-Isopropyl-phenyl)-6-prop-2-ynyloxy-quinazoline-2-carboxylic acid (3-trifluoromethyl-phenyl)-amide;
4-(4-Isopropyl-phenyl)-6-prop-2-ynyloxy-quinazoline-2-carboxylic acid (4-acetylamino-3-trifluoromethyl-phenyl)-amide;
4-(4-Isopropyl-phenyl)-6-prop-2-ynyloxy-quinazoline-2-carboxylic acid (3-methoxy-5-trifluoromethyl-phenyl)-amide;
4-(4-Isopropyl-phenyl)-6-prop-2-ynyloxy-quinazoline-2-carboxylic acid (3,5-bis-trifluoromethyl-phenyl)-amide;
4-(4-Isopropyl-phenyl)-6-prop-2-ynyloxy-quinazoline-2-carboxylic acid (3-fluoro-5-trifluoromethyl-phenyl)-amide;
4-(4-Isopropyl-phenyl)-6-prop-2-ynyloxy-quinazoline-2-carboxylic acid (4-fluoro-3-trifluoromethyl-phenyl)-amide;
3-{[4-(4-Isopropyl-phenyl)-6-prop-2-ynyloxy-quinazoline-2-carbonyl]-amino}-2-methyl-benzoic acid methyl ester;
3-{[4-(4-Isopropyl-phenyl)-6-prop-2-ynyloxy-quinazoline-2-carbonyl]-amino}-4-methyl-benzoic acid methyl ester;
3-{[4-(4-Isopropyl-phenyl)-6-prop-2-ynyloxy-quinazoline-2-carbonyl]-amino}-4-methoxy-benzoic acid methyl ester;
5-{[4-(4-Isopropyl-phenyl)-6-prop-2-ynyloxy-quinazoline-2-carbonyl]-amino}-isophthalic acid dimethyl ester;
4-{[4-(4-Isopropyl-phenyl)-6-prop-2-ynyloxy-quinazoline-2-carbonyl]-amino}-phthalic acid dimethyl ester;
4-(4-Isopropyl-phenyl)-6-prop-2-ynyloxy-quinazoline-2-carboxylic acid (3,5-dichloro-phenyl)-amide;
4-(4-Isopropyl-phenyl)-6-prop-2-ynyloxy-quinazoline-2-carboxylic acid (3,4-dichloro-phenyl)-amide;
4-(4-Isopropyl-phenyl)-6-prop-2-ynyloxy-quinazoline-2-carboxylic acid (3-chloro-4-fluoro-phenyl)-amide;
4-(4-Isopropyl-phenyl)-6-prop-2-ynyloxy-quinazoline-2-carboxylic acid (4-chloro-3-trifluoromethyl-phenyl)-amide;
5-{[4-(4-Isopropyl-phenyl)-6-prop-2-ynyloxy-quinazoline-2-carbonyl]-amino}-pyridine-2-carboxylic acid methyl ester;
5-{[4-(4-Isopropyl-phenyl)-6-prop-2-ynyloxy-quinazoline-2-carbonyl]-amino}-nicotinic acid methyl ester;
5-{[4-(4-Isopropyl-phenyl)-6-prop-2-ynyloxy-quinazoline-2-carbonyl]-amino}-nicotinic acid isopropyl ester;
[4-(4-Isopropyl-phenyl)-6-prop-2-ynyloxy-quinazolin-2-yl]-pyrrol-1-yl-methanone;
4-(4-Isopropyl-phenyl)-6-prop-2-ynyloxy-quinazoline-2-carboxylic acid (5-methyl-1H-pyrazol-3-yl)-amide;
(2-{[4-(4-Isopropyl-phenyl)-6-prop-2-ynyloxy-quinazoline-2-carbonyl]-amino}-thiazol-4-yl)-acetic acid ethyl ester;
4-(4-Isopropyl-phenyl)-6-prop-2-ynyloxy-quinazoline-2-carboxylic acid naphthalen-1-ylamide;
4-(4-Isopropyl-phenyl)-6-prop-2-ynyloxy-quinazoline-2-carboxylic acid isoquinolin-8-ylamide;
4-(4-Isopropyl-phenyl)-6-prop-2-ynyloxy-quinazoline-2-carboxylic acid phthalazin-5-ylamide;
4-(4-Isopropyl-phenyl)-6-prop-2-ynyloxy-quinazoline-2-carboxylic acid quinolin-5-ylamide;
4-(4-Isopropyl-phenyl)-6-prop-2-ynyloxy-quinazoline-2-carboxylic acid quinolin-8-ylamide;
4-(4-Isopropyl-phenyl)-6-prop-2-ynyloxy-quinazoline-2-carboxylic acid isoquinolin-4-ylamide;
4-(4-Isopropyl-phenyl)-6-prop-2-ynyloxy-quinazoline-2-carboxylic acid (5-acetyl-quinolin-8-yl)-amide;
4-(4-Isopropyl-phenyl)-6-prop-2-ynyloxy-quinazoline-2-carboxylic acid (3-bromo-6-methoxy-quinolin-8-yl)-amide;
4-(4-Isopropyl-phenyl)-6-prop-2-ynyloxy-quinazoline-2-carboxylic acid quinolin-2-ylamide;
4-(4-Isopropyl-phenyl)-6-prop-2-ynyloxy-quinazoline-2-carboxylic acid quinolin-6-ylamide;
4-(4-Isopropyl-phenyl)-6-prop-2-ynyloxy-quinazoline-2-carboxylic acid (2-methyl-quinolin-6-yl)-amide;
(6-{[4-(4-Isopropyl-phenyl)-6-prop-2-ynyloxy-quinazoline-2-carbonyl]-amino}-quinolin-8-yloxy)-acetic acid ethyl ester;
4-(4-Isopropyl-phenyl)-6-prop-2-ynyloxy-quinazoline-2-carboxylic acid (1H-benzoimidazol-4-yl)-amide;
4-(4-Isopropyl-phenyl)-6-prop-2-ynyloxy-quinazoline-2-carboxylic acid benzothiazol-2-ylamide;
4-(4-Isopropyl-phenyl)-6-prop-2-ynyloxy-quinazoline-2-carboxylic acid (benzo[1,3]dioxol-5-ylmethyl)-amide;
4-(4-Isopropyl-phenyl)-6-prop-2-ynyloxy-quinazoline-2-carboxylic acid (thiophen-2-ylmethyl)-amide;
4-(4-Isopropyl-phenyl)-6-prop-2-ynyloxy-quinazoline-2-carboxylic acid 3-methoxy-phenyl ester;
1-(4-Isopropyl-phenyl)-7-prop-2-ynyloxy-isoquinoline-3-carboxylic acid ethyl ester;
1-(4-Isopropyl-phenyl)-7-prop-2-ynyloxy-isoquinoline-3-carboxylic acid 1,2-dimethyl-propyl ester;
1-(4-Isopropyl-phenyl)-7-prop-2-ynyloxy-isoquinoline-3-carboxylic acid isobutyl ester;
1-(4-Isopropyl-phenyl)-7-prop-2-ynyloxy-isoquinoline-3-carboxylic acid cyclopropylmethyl ester;
1-(4-Isopropyl-phenyl)-7-prop-2-ynyloxy-isoquinoline-3-carboxylic acid benzyl ester;
1-(4-Isopropyl-phenyl)-7-prop-2-ynyloxy-isoquinoline-3-carboxylic acid 2-methoxy-benzyl ester;
1-(4-Isopropyl-phenyl)-7-prop-2-ynyloxy-isoquinoline-3-carboxylic acid 3-methoxy-benzyl ester;
1-(4-Isopropyl-phenyl)-7-prop-2-ynyloxy-isoquinoline-3-carboxylic acid 4-methoxycarbonyl-benzyl ester;
1-(4-Isopropyl-phenyl)-7-prop-2-ynyloxy-isoquinoline-3-carboxylic acid phenethyl ester;
1-(4-Isopropyl-phenyl)-7-prop-2-ynyloxy-isoquinoline-3-carboxylic acid 1-phenyl-ethyl ester;
1-(4-Isopropyl-phenyl)-7-prop-2-ynyloxy-isoquinoline-3-carboxylic acid [3-(2-hydroxy-ethanesulfonyl)-phenyl]-amide;
[1-(4-Isopropyl-phenyl)-7-prop-2-ynyloxy-isoquinolin-3-yl]-(3-methoxy-phenyl)-methanone; and
[1-(4-Isopropyl-phenyl)-7-prop-2-ynyloxy-isoquinolin-3-yl]-(4-methoxy-phenyl)-methanone;

### Claim 8 (depends on 1)

A pharmaceutical composition comprising a compound of claim 1 in association with a pharmaceutically acceptable excipient, diluent or carrier.

### Claim 9

(canceled)

### Claim 10 (depends on 1)

A method for preventing or treating bone conditions which are associated with increased calcium depletion or resorption or in which stimulation of bone formation and calcium fixation in the bone is desirable in which an effective amount of a compound of claim 1 or a pharmaceutically-acceptable and -cleavable ester, or acid addition salt thereof is administered to a patient in need of such treatment.

### Claim 11

A process for preparation of a compound of formula (I) in free or salt form, comprising the step of:
(i) for cases where Q is N, reacting a compound of formula (III) with a compound of formula (IV) and an ammonium salt in the presence of a suitable solvent:
or
(ii) reacting a compound of formula V
wherein LG represents a suitable leaving group;
with an organometallic reagent of formula VI:
X-Met VI
under suitable anhydrous conditions; or
(iii) reacting a compound of formula Va
with an organometallic reagent of formula VI:
X-Met VI
under suitable anhydrous conditions followed by oxidation to the carbonyl compound by an appropriate oxidation agent; or
(iv) reacting a compound of formula VII
with a compound X—H wherein the H forms part of an amino or hydroxy group, the reaction being carried out in the presence of a coupling reagent; or
(v) reacting a compound of formula VIII
wherein Hal is halogen or a leaving group
with a compound X—H wherein the H forms part of an amino or hydroxy group, the reaction being carried out in the presence of a coupling reagent.

### Claim 12

(canceled)

### Claim 13

(canceled)

### Claim 14 (depends on 4)

A compound according to claim 4 wherein R2′ is isopropyl, t-butyl or cyclopropyl.

### Claim 15 (depends on 3)

A compound according to claim 3 wherein X′ is optionally substituted (aryl, heteroaryl, heterocycloalkyl, arylamino, heteroarylamino, aryl C1-C4 alkylamino, heteroaryl C1-C4 alkylamino, aryloxy, heteroaryloxy, C-C6 alkyloxy, aryl C1-C4 alkyloxy, heteroaryl C1-C4 alkyloxy).

### Claim 16 (depends on 8)

A pharmaceutical composition of claim 8 further comprising a second substance selected from: calcium, a calcitonin or an analogue or derivative thereof, a steroid hormone, a partial estrogen agonist or estrogen-gestagen combination, a SERM (Selective Estrogen Receptor Modulator), a RANKL antibody, a cathepsis K inhibitor, vitamin D or an analogue thereof or PTH, a PTH fragment or a PTH derivative for simultaneous, separate or sequential treatment.
